Japan approves Gilead Sciences#39; remdesivir as COVID-19 drug
Japan reached the decision just three days after the US drugmaker filed for fast-track approval for the treatment.
Japan reached the decision just three days after the US drugmaker filed for fast-track approval for the treatment.